Ovary function is preserved in transgender men at one year of testosterone therapy

NEW ORLEANS–Transgender men preserve their fertility potential even after one year of treatment with the male hormone testosterone, according to a study that will be presented Saturday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La. “Our research shows for the first time that after one year of testosterone treatment, ovary function…

Details

Levothyroxine treatment in women with thyroid antibodies may not increase live birth rate

Treating women with thyroid antibodies but a normal thyroid function with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research led by the University of Birmingham suggests. The research, which was led by researchers from the Institute of Metabolism and Systems Research, Birmingham Clinical Trials Unit, the…

Details

New hybrid closed loop insulin pump proves hard to use for some patients with diabetes

NEW ORLEANS–Among first-time users of a new insulin pump that automatically delivers insulin to people with type 1 diabetes, nearly one-fifth stopped using the device, primarily because of difficulties meeting the technical demands system, researchers say. Results of a real-world study of the hybrid closed loop insulin pump (Medtronic MiniMed 670G) will be presented Sunday…

Details

Treating diabetes in older adults requires simpler medication regimens, looser glycemic targets

NEW ORLEANS–Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society. The Society debuted the guideline during a press conference on the opening day of ENDO 2019, its annual meeting in New Orleans, La. The…

Details